×
About 7,297 results

ALLMedicine™ Hepatic Encephalopathy Center

Research & Reviews  3,579 results

Hepatic encephalopathy: Novel insights into classification, pathophysiology and therapy.
https://doi.org/10.1016/j.jhep.2020.07.013
Journal of Hepatology; Rose CF, Amodio P et. al.

Oct 24th, 2020 - Hepatic encephalopathy (HE) is a frequent and serious complication of both chronic liver disease and acute liver failure. HE manifests as a wide spectrum of neuropsychiatric abnormalities, from subclinical changes (mild cognitive impairment) to ma...

MASQ-HE: Unmasking the Predictors of Overt Hepatic Encephalopathy?
https://doi.org/10.14309/ajg.0000000000001010
The American Journal of Gastroenterology; Soni D, Roy A et. al.

Oct 20th, 2020 - MASQ-HE: Unmasking the Predictors of Overt Hepatic Encephalopathy?|2020|Soni D,Roy A,De A,Verma N,Singh V,|

Efficacy and Safety of Ornithine Phenylacetate for Treating Overt Hepatic Encephalopath...
https://doi.org/10.1016/j.cgh.2020.10.019
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association; Rahimi RS, Safadi R et. al.

Oct 18th, 2020 - Hepatic encephalopathy (HE) is associated with increased morbidity, mortality, and healthcare resource use. In this phase 2b study, we evaluated the efficacy and safety of ornithine phenylacetate (OP), an ammonia scavenger, in hospitalized patient...

Combined PEG3350 Plus Lactulose Results in Early Resolution of Hepatic Encephalopathy a...
https://doi.org/10.1097/MCG.0000000000001450
Journal of Clinical Gastroenterology; Ahmed S, Premkumar M et. al.

Oct 16th, 2020 - Acute-on-chronic liver failure (ACLF) is associated with high short-term mortality in those with hepatic encephalopathy (HE). Polyethylene glycol (PEG) 3350 electrolyte solution can ensure rapid gut catharsis, which may resolve HE more effectively...

Peripheral and central glutamate dyshomeostasis in neurodegenerative disorders.
https://doi.org/10.2174/1570159X18666201015161919
Current Neuropharmacology; Onaolapo AY, Onaolapo OJ

Oct 16th, 2020 - Glutamate's role as the major excitatory neurotransmitter of the mammalian central nervous system requires that its brain concentrations be kept tightly-controlled. However, in hepatic encephalopathy resulting from liver dysfunction; disruption of...

see more →

Guidelines  23 results

KASL clinical practice guidelines for liver cirrhosis: Varices, hepatic encephalopathy,...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7160350
Clinical and Molecular Hepatology;

Jan 10th, 2020 - KASL clinical practice guidelines for liver cirrhosis: Varices, hepatic encephalopathy, and related complications.|2020| ,|

Chinese guidelines on management of hepatic encephalopathy in cirrhosis.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6767982
World Journal of Gastroenterology; Xu XY, Ding HG et. al.

Oct 2nd, 2019 - The Chinese Society of Hepatology developed the current guidelines on the management of hepatic encephalopathy in cirrhosis based on the published evidence and the panelists' consensus. The guidelines provided recommendations for the diagnosis and...

Consensus Report by the Pediatric Acute Lung Injury and Sepsis Investigators and Pediat...
https://doi.org/10.1016/j.bbmt.2017.08.035
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation; Ovchinsky N, Frazier W et. al.

Sep 5th, 2017 - Some patients with veno-occlusive disease (VOD) have multiorgan dysfunction, and multiple teams are involved in their daily care in the pediatric intensive care unit. Cardiorespiratory dysfunction is critical in these patients, requiring immediate...

How to diagnose and manage hepatic encephalopathy: a consensus statement on roles and r...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4885589
European Journal of Gastroenterology & Hepatology; Shawcross DL, Dunk AA et. al.

Nov 25th, 2015 - Hepatic encephalopathy is defined as brain dysfunction caused by liver insufficiency and/or portosystemic shunting. Symptoms include nonspecific cognitive impairment, personality changes and changes in consciousness. Overt (symptomatic) hepatic en...

Hepatic Encephalopathy in Chronic Liver Disease: 2014 Practice Guideline by the American Ass...
https://www.aasld.org/sites/default/files/guideline_documents/hepaticencephalopathy82014.pdf
Hendrik Vilstrup, Piero Amodio et. al.

Jul 31st, 2014 - Hepatic encephalopathy (HE) is a frequent complication and one of the most debilitating manifestations of liver disease, severely affecting the lives of patients and their caregivers. Furthermore, cognitive impairment associated with cirrhosis res.

see more →

Drugs  7 results see all →

Clinicaltrials.gov  3,625 results

Hepatic encephalopathy: Novel insights into classification, pathophysiology and therapy.
https://doi.org/10.1016/j.jhep.2020.07.013
Journal of Hepatology; Rose CF, Amodio P et. al.

Oct 24th, 2020 - Hepatic encephalopathy (HE) is a frequent and serious complication of both chronic liver disease and acute liver failure. HE manifests as a wide spectrum of neuropsychiatric abnormalities, from subclinical changes (mild cognitive impairment) to ma...

MASQ-HE: Unmasking the Predictors of Overt Hepatic Encephalopathy?
https://doi.org/10.14309/ajg.0000000000001010
The American Journal of Gastroenterology; Soni D, Roy A et. al.

Oct 20th, 2020 - MASQ-HE: Unmasking the Predictors of Overt Hepatic Encephalopathy?|2020|Soni D,Roy A,De A,Verma N,Singh V,|

Efficacy and Safety of Ornithine Phenylacetate for Treating Overt Hepatic Encephalopath...
https://doi.org/10.1016/j.cgh.2020.10.019
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association; Rahimi RS, Safadi R et. al.

Oct 18th, 2020 - Hepatic encephalopathy (HE) is associated with increased morbidity, mortality, and healthcare resource use. In this phase 2b study, we evaluated the efficacy and safety of ornithine phenylacetate (OP), an ammonia scavenger, in hospitalized patient...

Combined PEG3350 Plus Lactulose Results in Early Resolution of Hepatic Encephalopathy a...
https://doi.org/10.1097/MCG.0000000000001450
Journal of Clinical Gastroenterology; Ahmed S, Premkumar M et. al.

Oct 16th, 2020 - Acute-on-chronic liver failure (ACLF) is associated with high short-term mortality in those with hepatic encephalopathy (HE). Polyethylene glycol (PEG) 3350 electrolyte solution can ensure rapid gut catharsis, which may resolve HE more effectively...

Peripheral and central glutamate dyshomeostasis in neurodegenerative disorders.
https://doi.org/10.2174/1570159X18666201015161919
Current Neuropharmacology; Onaolapo AY, Onaolapo OJ

Oct 16th, 2020 - Glutamate's role as the major excitatory neurotransmitter of the mammalian central nervous system requires that its brain concentrations be kept tightly-controlled. However, in hepatic encephalopathy resulting from liver dysfunction; disruption of...

see more →

News  63 results

Inner demons
https://www.mdedge.com/gihepnews/article/212611/mixed-topics/inner-demons?channel=41022

Dec 1st, 2019 - Julia Brennan sings about inner demons. They just won’t go away and they don’t play fair with angels.

Blocking TLR9 may halt brain edema in acute liver failure
https://www.mdedge.com/gihepnews/article/211698/liver-disease/blocking-tlr9-may-halt-brain-edema-acute-liver-failure?channel=346
Will Pass, MDedge News

Nov 6th, 2019 - A toll-like receptor 9 (TLR9) antagonist may eventually be used to combat brain edema in acute liver failure, according to investigators. This prediction is based on results of a recent study involving mouse models, which showed that ODN2088, a TL.

Fecal microbiota transplant shows promise for hepatic encephalopathy
https://www.mdedge.com/internalmedicine/article/199898/hepatology/fecal-microbiota-transplant-shows-promise-hepatic?channel=39313
Mitchel L. Zoler

Apr 30th, 2019 - VIENNA – A single, oral treatment with fecal microbiota transplant was safe and well tolerated, and showed suggestive evidence of clinical improvement in patients with cirrhosis and recurrent hepatic encephalopathy in a phase 1 randomized study wi.

Oral Fecal Capsule Promising for Hepatic Encephalopathy
https://www.medscape.com/viewarticle/912024

Apr 18th, 2019 - VIENNA — For patients with cirrhosis who experience recurrent hepatic encephalopathy, an oral formulation of fecal microbiota is safe and effective, new research shows. "This is an underserved population for whom we have nothing left to offer," sa...

Child-Pugh class does not affect HE recurrence in patients taking rifaximin
https://www.mdedge.com/gihepnews/article/178076/gastroenterology/child-pugh-class-does-not-affect-he-recurrence-patients
Jeff Craven, MDedge News

Oct 25th, 2018 - PHILADELPHIA – Although overt hepatic encephalopathy was reduced in patients taking rifaximin with baseline Child-Pugh class A, B, or C, there was no significant difference in the reduction based on the level of hepatic impairment, according to a.

see more →